News

ONWARD Completes $32 Million Financing Round

Details

ONWARD, announced the Company has successfully completed a $32M financing. The round was led by Invest-NL, the Dutch impact investor, and Olympic Investments, the private investment arm of the Onassis Foundation. Several additional new investors and all of ONWARD’s existing investors also participated in the financing, including leading medical technology investors LSP, INKEF Capital, Gimv, and Wellington Partners. 

Clinical Data with ImCheck’s ICT01 to be Presented at AACR: Positive Results Observed on Safety, Activation of Gamma 9 Delta 2 T Cells and Anti-tumor Immune Response

Details

ICT01 activates γ9δ2 T cells that rapidly migrate out of the circulation and secrete IFNγ and TNFα leading to an expanded immune system activation. 

UroMems Completes €23 Million Series B Financing

Details

UroMems, announced that it has raised an additional €7 million in a second tranche of its previously announced Series B financing round completed in May 2020.

  1. Immatics Presents Data Update on Dose Escalation from Ongoing ACTengine® Cell Therapy Programs
  2. Partner Therapeutics Announces Partnership with SIRS Therapeutics and F4 Pharma to Explore Potential Uses for FX06 in Biodefense Applications
  3. eGenesis Announces $125 Million Series C Financing
  4. Creative Balloons closes €15 million growth financing and appoints Frank Gehres as CEO
© Wellington Partners, 2021.